Summer 1995



h Plasma metanephrines in the diagnosis of pheochromocytoma (Jul 95 AIM)
h Divergent effects of dihydropyridines and phenylalkalamine calcium channel antagonist classes on autonomic function in human hypertension (Jul 95 Hyp)
h Calcium supplementation attenuates enhanced platelet function in salt-loaded mildly hypertensive patients (Jul 95 Hyp)
h Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients (Jul 95 Hyp)
h Efficacy and safety of losartan (Aug 95 CJC)
h The risk of myocardial infarction associated with antihypertensive drug therapy (Aug 95 JAMA)
h Left ventricular hypercontractility in hypertensive patients with anginal pain and normal coronary angiograms (Aug 95 ZFK)
h Alterations of calcium metabolism and of parathyroid function in primary aldosteronism and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas (Sep 95 AJH)
h Use of antihypertensive drugs and trends in blood pressure in the elderly (Sep 95 ArIM)
h Birth weight and blood pressure: Cross-sectional and longitudinal relations in childhood (Sep 95 BMJ)
h Nifedipine: dose-related increase in mortality in patients with coronary heart disease (Sep 95 Circ)
h Is white coat hypertension associated with arterial disease or left ventricular hypertrophy? (Sep 95 Hyp)
h Isolated diastolic hypertension: A favorable finding among young and middle-aged hypertensive patients (Sep 95 Hyp)
h White coat effect in treated hypertensive patients: Sex differences (Sep 95 JHH)
h Dexamethasone-sensitive hyperaldosteronism with adrenal adenoma - Clinical, biological, and genetic analysis (Sep 95 PM)

Dialysis, Chronic Renal Failure

d Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation (Jul 95 AJKD)
d Beneficial effect of low-dose transdermal estrogen on bleeding time and clinical bleeding in uremia (Jul 95 AJKD)
d Total body nitrogen as a prognostic marker in maintenance dialysis patients (Jul 95 JASN)
d Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia (Jul 95 JCI)
d Renovascular disease in older patients beginning renal replacement therapy (Jul 95 KI)
d Theory and validation of access flow measurement by dilution technique during hemodialysis (Jul 95 KI)
d Lipid-lowering therapy in patients with renal disease (Jul 95 KI)
d Effect of dialysate temperature on central hemodynamics and urea kinetics (Jul 95 KI)
d Late outcome of a controlled trial of enalapril treatment in progressive renal failure. Hard end-points and influence of proteinuria. (Jul 95 NDT)
d Diagnosis of iron deficiency anemia in renal failure patients in the post-erythropoietin era (Aug 95 AJKD)
d Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis (Aug 95 AJKD)
d A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis and a comparison of causes of death (two back-to-back papers) (Aug 95 JASN)
d Epidemic aluminum intoxication in hemodialysis patients traced to use of an aluminum pump (Aug 95 KI)
d Mechanisms of hypoalbuminemia in hemodialysis patients (Aug 95 KI)
d Cross-sectional comparison of malnutrition in continuous ambulatory peritoneal dialysis and hemodialysis patients (Sep 95 AJKD)
d Enalapril treatment of post-transplant erythrocytosis: Efficacy independent of circulating erythropoietin levels (Sep 95 AJKD)
d Hypertension in the hemodialysis population: A survey of 649 patients (Sep 95 AJKD)
d Rinsing time and disinfectant release of reused dialyzers: Comparison of formaldehyde, hypochlorite, warexin, and renalin (Sep 95 AJKD)
d Vancomycin removal by high-flux polysulfone hemodialysis membranes in critically ill patients with end-stage renal disease (Sep 95 AJKD)
d Dialysis arthropathy: Outcome after renal transplantation (Sep 95 AJM)
d Bezafibrate in the management of vascular access and dialyzer thrombosis (Sep 95 DT)
d Evidence that reduced lipoprotein lipase activity is not a primary pathogenetic factor for hypertriglyceridemia in renal failure (Sep 95 KI)
d Accuracy of urea removal estimated by kinetic models (Sep 95 KI)
d Antiphospholipids in hemodialysis patients: Relationship between lupus anticoagulant and thrombosis (Sep 95 KI)
d Erythropoietin enhances vascular responsiveness to norepinephrine in renal failure (Sep 95 KI)
d Long-term effects of reduced renal mass in humans (Sep 95 KI)
d High resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia (Sep 95 KI)
d Calcium-regulated parathyroid hormone secretion in adynamic renal osteodystrophy (Sep 95 KI)
d "Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis (Sep 95 KI)
d Effects of selenium supplementation on immune parameters in chronic renal failure patients on haemodialysis (Sep 95 NDT)
d Atherogenic lipid profile in lipoprotein(a) in relation to serum albumin in haemodialysis patients (Sep 95 NDT)

Clinical Nephrology

c Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate (Aug 95 JASN)
c Renal papillary necrosis: a sixteen-year clinical experience (Aug 95 JASN)
c Hypocalcemia after acute phosphate load is secondary to reduced calcium efflux from bone: Studies in patients with minimal renal function and varying parathyroid activity. (Aug 95 JASN)
c Relationship between appearance of urinary red blood cell/white blood cell casts and the onset of renal relapse in systemic lupus erythematosus (Sep 95 AJKD)
c ANCA and anti-GBM antibodies: two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis (Sep 95 AJKD)
c Evaluation of dopexamine hydrochloride as a renoprotective agent during aortic surgery (Sep 95 AVS)
c Hepatitis C virus associated membranous glomerulonephritis (Sep 95 CN)
c Hantavirus nephropathy (Sep 95 KI)
c The PiZ gene of alpha-1 antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis (Sep 95 KI)
c Chronic hypokalemia of adults: Gitelman's syndrome is frequent but classical Bartter's syndrome is rare (Sep 95 NDT)
c Potential nephrotoxicity of intravenous infusions of naftidrofuryl oxalate (Sep 95 NDT)

UP Use back arrow on your browser to go back to HDCN home page (faster) or click on the arrow.